AMG:ETR
Amgen
404,15 €
arrow_upward
+0,70%(+2,80) 1K
28-okt, 17:35:39 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMG tikeri uchun statistika yaratilmoqda...
Ochish
400,05 €
Yuqori
407,40 €
Past
397,30 €
Bozor kapitali
244,27 mlrd
Oʻrtacha hajm
557,00
Hajmi
692,00
52 haftalik eng yuqori
407,40 €
52 haftalik eng past
247,65 €
Xodimlar soni
32 ming
Ochish
400,05 €
Yuqori
407,40 €
Past
397,30 €
Bozor kapitali
244,27 mlrd
Oʻrtacha hajm
557,00
Hajmi
692,00
52 haftalik eng yuqori
407,40 €
52 haftalik eng past
247,65 €
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 kun oldin
Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
Investor's Business Daily
·
1 kun oldin
Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results
The Motley Fool
·
1 kun oldin
Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
Investing.com Nigeria
·
1 kun oldin
Amgen appoints former Yum! Brands CEO to board of directors By Investing.com
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytamgen.com